Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-led ...
GlobalData on MSN17h
AccuStem Sciences acquires licence for lung cancer screening testClinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) ...
Affinity Technologies, Inc. today released a study of a complex clinical case in which CyPath® Lung's real-time assessment of the lung microenvironment identified a hidden recurrence of breast cancer ...
LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has entered into a research ...
NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...
The cancer can be challenging to diagnose since some symptoms go undetected and may resemble those of other health issues ...
DO you snore? Between 25 to 50 percent of adults snore regularly, and occasional snoring is almost universal. If one snores and wakes up tired and feeling sleep-deprived most ...
Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback